HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 28, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; ...

In the early 1990s, a pivotal randomised trial sponsored by the National Institute of Neurological Disorders and Stroke ...

Research has indicated that patients needing care prefer to receive it in their homes rather than in a hospital setting.

Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...

Clinicians are advised to screen patients for conditions that would have rendered them ineligible to participate in the ...

An electronic tool has streamlined the screening and management of stroke patients eligible for research studies, allowing co ...

In this randomized controlled trial, total hip replacement (THR) was superior to resistance training in improving hip pain ...

In the US, liraglutide, semaglutide, and tirzepatide are currently under investigation for their ability to stimulate weight ...

Itamaraty explained that it is not advocating the inclusion or exclusion of any given country, but merely advocated the creation of criteria and principles to guide the choice of new BRICS members.

A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.

New research has found that nearly 137 million adults—or more than half of all U.S. adults—are eligible for semaglutide ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...